Pancreatic pseudocysts: Prognostic factors for their development and their spontaneous resolution in the setting of acute pancreatitis

Lankisch, P. G.; Weber-Dany, Bettina; Maisonneuve, Patrick; Lowenfels, Albert B.

doi:10.1016/j.pan.2012.02.007

Cited by 44 publications

(34 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Lankisch et al [19] found that six (2%) of 245 patients who had no initial acute fluid collection had newly developed pancreatic pseudocysts at the third month ultrasound follow up, and suggested that follow-up imaging three months later is required in patients with a first severe attack of acute pancreatitis and fluid collections at discharge. Similarly, we found that FUCT showed a newly developed pancreatic collection such as pseudocyst or walled-off necrosis in 16 (14.6%) patients without prior fluid collection.…”

Section: Discussionmentioning

confidence: 99%

Usefulness of scheduled follow-up CT in discharged patients with acute pancreatitis

et al. 2015

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Usefulness of scheduled follow-up CT in discharged patients with acute pancreatitis

et al. 2015

View full text Add to dashboard Cite

“…Very low quality evidence suggested that the endoscopic minimally invasive step-up approach resulted in fewer adverse events than the video-assisted minimally invasive step-up approach but increasing the number of procedures required for treatment. In the future the TENSION trial would elucidate with a higher level of evidence which of this procedures or combination of procedures obtain the best outcomes [66].…”

Section: Local Complications Treatmentmentioning

confidence: 99%

Acute Pancreatitis, Actualization and Evidence Based Management

Andrade¹,

Delgado²,

Corona³

et al. 2017

Arch Clin Gastroenterol

View full text Add to dashboard Cite

Acute pancreatitis (AP) is a systemic immunoinfl ammatory response to auto-digestion of the pancreas and peri-pancreatic organs. It is a frequent gastrointestinal disease with an important morbimortality, reaching 30% in severe cases. Different studies and reviews by international groups have developed multiple classifi cation systems to assess the severity and address the correct management along time, identifying the better molecular markers, clinical outcome determinants and reaching conservative management as the angular piece in AP. In this review we present a compilation of the latest studies and international consensus about AP physiology, etiology, risk factors, diagnosis, severity assessment, imaging and treatment.

show abstract

“…The following clinical symptoms: abdominal pain, nausea and vomiting, gastrointestinal bleeding are also indications for intervention. Relative indications for the pseudocyst treatment include: diameter more than 4 cm, regression lack or progression within 6 weeks, chronic pancreatitis, pancreatic duct anomaly or lithiasis, difficulties in differential diagnosis with neoplastic cysts [2,79].…”

Section: Choice Of the Management Type In Pancreatic Pseudocystsmentioning

confidence: 99%

Pancreatic cysts: etiology, diagnosis and management

Jabłońska

2014

Open Medicine

View full text Add to dashboard Cite

AbstractPancreatic cysts involve a wide spectrum of pathologies from post-inflammatory cysts to malignant neoplasms. Pancreatic pseudocysts, serous cystadenomas, mucinous cystadenomas, intraductal papillary mucinous neoplasms (IPMNs) and solid pseudopapillary tumors occur most frequently. Differential diagnosis involves the following imaging investigations: transabdominal ultrasonography (TUS), contrast enhanced ultrasonography (CEUS) and endoscopic ultrasonography (EUS), computed tomography (CT), magnetic resonance (MR) and magnetic resonance cholangiopancretography (MRCP), endoscopic retrograde cholangiopancretography (ERCP). The cyst fluid cytology is performed in difficult differential diagnosis between pseudocysts and benign and potentially malignant or malignant tumors. Most frequently, viscosity, amylase, CEA and CA 19-9 levels are determined. Imaging findings should be correlated with cytology. The management depends on the cyst type and size. Small asymptomatic pseudocysts, serous cystadenomas and branchduct IPMNs should be carefully observed, whereas symptomatic large or uncertain serous cystadenomas and cystadenocarcinomas, mucinous cystadenomas and cystadenocarcinomas, main-duct IPMNs and large branch-duct IPMNs with malignant features, serous and mucinous cystadenocarcinomas, and solid pseudopapillary tumors require surgery. Pseudocysts are usually drained. Percutaneous / EUS-guided or surgical cyst drainage can be performed. Complicated and uncertain pseudocysts and cystic tumors need surgical resection. The type of surgery depends on cyst location and size and includes proximal, central, distal, total pancreatectomies and enucleation.

show abstract

Pancreatic pseudocysts: Prognostic factors for their development and their spontaneous resolution in the setting of acute pancreatitis

Cited by 44 publications

References 17 publications

Usefulness of scheduled follow-up CT in discharged patients with acute pancreatitis

Usefulness of scheduled follow-up CT in discharged patients with acute pancreatitis

Acute Pancreatitis, Actualization and Evidence Based Management

Pancreatic cysts: etiology, diagnosis and management

Contact Info

Product

Resources

About